Phase 1 Plasma Cell Disorder Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Plasma Cell Disorder
University of Maryland, Baltimore30 enrolled1 locationNCT07075510
Recruiting
Phase 1
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
Plasma Cell Disorder
University of Arkansas18 enrolled1 locationNCT06313502
Recruiting
Phase 1Phase 2
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Multiple MyelomaPlasma Cell Disorder
Heidelberg Pharma AG78 enrolled16 locationsNCT04879043